Evidence map›Paper›PMID 37841434›Full record

ArticleFrontiers in oncology2023

Leukemic conversion involving

Petruta Gurban, Cristina Mambet, Anca Botezatu, Laura G Necula, Ana I Neagu, Lilia Matei, Ioana M Pitica, Saviana Nedeianu, Mihaela Chivu-Economescu, Coralia Bleotu and 9 more

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 3 countries.

Petruta GurbanCellular and Molecular Pathology Department, Stefan S. Nicolau Institute of Virology, Romanian Academy, Bucharest, Romania.
Cristina MambetCellular and Molecular Pathology Department, Stefan S. Nicolau Institute of Virology, Romanian Academy, Bucharest, Romania.
Anca BotezatuMolecular Virology Department, Stefan S. Nicolau Institute of Virology, Romanian Academy, Bucharest, Romania.
Laura G NeculaCellular and Molecular Pathology Department, Stefan S. Nicolau Institute of Virology, Romanian Academy, Bucharest, Romania.
Ana I NeaguCellular and Molecular Pathology Department, Stefan S. Nicolau Institute of Virology, Romanian Academy, Bucharest, Romania.
Lilia MateiCellular and Molecular Pathology Department, Stefan S. Nicolau Institute of Virology, Romanian Academy, Bucharest, Romania.
Ioana M PiticaCellular and Molecular Pathology Department, Stefan S. Nicolau Institute of Virology, Romanian Academy, Bucharest, Romania.
Saviana NedeianuCellular and Molecular Pathology Department, Stefan S. Nicolau Institute of Virology, Romanian Academy, Bucharest, Romania.
Mihaela Chivu-EconomescuCellular and Molecular Pathology Department, Stefan S. Nicolau Institute of Virology, Romanian Academy, Bucharest, Romania.
Coralia BleotuCellular and Molecular Pathology Department, Stefan S. Nicolau Institute of Virology, Romanian Academy, Bucharest, Romania.
Marius AtamanCellular and Molecular Pathology Department, Stefan S. Nicolau Institute of Virology, Romanian Academy, Bucharest, Romania.
Gabriela MocanuDepartment of Hematology, Coltea Clinical Hospital, Bucharest, Romania.
Carmen SagunaDepartment of Radiology, Oncology, and Hematology, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
Anca G PavelCytogenomic Medical Laboratory Ltd., Bucharest, Romania.
Danae StambouliCytogenomic Medical Laboratory Ltd., Bucharest, Romania.
Elise SepulchreDe Duve Institute, Université Catholique de Louvain, Brussels, Belgium.
Gabriela AntonMolecular Virology Department, Stefan S. Nicolau Institute of Virology, Romanian Academy, Bucharest, Romania.
Carmen C DiaconuCellular and Molecular Pathology Department, Stefan S. Nicolau Institute of Virology, Romanian Academy, Bucharest, Romania.
Stefan N ConstantinescuDe Duve Institute, Université Catholique de Louvain, Brussels, Belgium.
Romanian Academy · ROCarol Davila University of Medicine and Pharmacy · ROClinical Emergency Hospital Bucharest · ROde Duve Institute · BEUCLouvain · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Somatic frameshift mutations in exon 9 of calreticulin (

Indexed as

acquired uniparental disomy (aUPD)case reporthepatitis C virus (HCV) cirrhosisNRASprimary myelofibrosis (PMF)targeted next-generation sequencing (NGS)type 1 calreticulin (CALR)

Identifiers

PMID37841434
PMCPMC10570518
OpenAlexW4387167576

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.